Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:11 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management L.P. | 5,243,623 6.1% | 1,680,721 (+47.17%) | View |
| 2024-02-14 4:10 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | Point72 Asset Management L.P. | 4,040,000 9.4% | 1,918,830 (+90.46%) | View |
| 2024-02-14 10:06 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Point72 Asset Management L.P. | 493,400 0.9% | -3,021,956 (-85.96%) | View |
| 2024-02-14 10:06 am Sale | 13G | GRITSTONE BIO INC GRTS | Point72 Asset Management L.P. | 3,974,873 4.2% | -3,727,958 (-48.40%) | View |
| 2024-02-14 10:04 am Sale | 13G | FIBROGEN INC FGEN | Point72 Asset Management L.P. | 1,643,844 1.7% | -4,637,801 (-73.83%) | View |
| 2024-02-14 10:03 am Sale | 13G | EOS ENERGY ENTERPRISES INC EOSE | Point72 Asset Management L.P. | 3,840,704 2% | -1,694,326 (-30.61%) | View |
| 2024-02-14 10:02 am Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management L.P. | 1,250,228 1.4% | -2,617,778 (-67.68%) | View |
| 2024-02-14 10:02 am Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | Point72 Asset Management L.P. | 2,500 0.3% | 2,500 (New Position) | View |
| 2024-02-14 10:01 am Sale | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management L.P. | 788,545 3% | -1,335,655 (-62.88%) | View |
| 2024-02-14 08:56 am Sale | 13G | VISTAGEN THERAPEUTICS INC VTGN | Point72 Asset Management L.P. | 822,334 3% | -743,495 (-47.48%) | View |
| 2024-02-14 07:16 am Purchase | 13G | FARFETCH LTD FTCH | Point72 Asset Management L.P. | 20,383,303 5.8% | 1,617,894 (+8.62%) | View |
| 2024-02-14 07:15 am Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management L.P. | 2,613,453 4.5% | -572,624 (-17.97%) | View |
| 2024-02-14 07:15 am Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Point72 Asset Management L.P. | 3,202,381 4.7% | -268,310 (-7.73%) | View |
| 2024-02-14 07:01 am Sale | 13G | SEMTECH CORP SMTC | Point72 Asset Management L.P. | 1,684,160 2.6% | -2,976,676 (-63.87%) | View |
| 2024-02-14 07:01 am Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Point72 Asset Management L.P. | 2,834,499 3.3% | -685,903 (-19.48%) | View |
| 2024-02-14 07:00 am Sale | 13G | BIOHAVEN RESH LTD. USD COM SHS BHVN | Point72 Asset Management L.P. | 2,552,822 3.2% | -1,508,521 (-37.14%) | View |
| 2024-02-14 06:45 am Sale | 13G | BIONOMICS LTD ADS BNOX | Point72 Asset Management L.P. | 59,580,000 4% | -59,512,680 (-49.97%) | View |
| 2024-02-14 06:45 am Sale | 13G | RAPID7 INC RPD | Point72 Asset Management L.P. | 1,877,611 3.1% | -1,214,659 (-39.28%) | View |
| 2024-02-14 06:30 am Sale | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 3,997,545 4.5% | -87,999 (-2.15%) | View |
| 2024-02-14 06:30 am Sale | 13G | CHEWY INC CHWY | Point72 Asset Management L.P. | 1,591,442 1.3% | -5,114,441 (-76.27%) | View |